{"id":576484,"date":"2021-11-24T16:32:02","date_gmt":"2021-11-24T16:32:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=576484"},"modified":"2021-11-24T16:32:02","modified_gmt":"2021-11-24T16:32:02","slug":"the-growing-geriatric-population-is-expected-to-drive-the-growth-of-drugeluting-stents-market","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/the-growing-geriatric-population-is-expected-to-drive-the-growth-of-drugeluting-stents-market_576484.html","title":{"rendered":"The growing geriatric population is expected to drive the growth of Drug-Eluting Stents market"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1637743041.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"The growing geriatric population is expected to drive the growth of Drug-Eluting Stents market\" src=\"https:\/\/www.abnewswire.com\/uploads\/1637743041.png\" alt=\"The growing geriatric population is expected to drive the growth of Drug-Eluting Stents market\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Drug-Eluting Stents Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">The Drug-Eluting Stents market is expected to grow due to a change in preference for drug-eluting stents over angioplasty.<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/0e5b2530d4c2e512228a41fd7ec49e66.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">DelveInsight&rsquo;s <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/drug-eluting-stents-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Drug-Eluting Stents market report<\/a><\/strong> provides a thorough comprehension of Drug-Eluting Stents and historical and forecasted Drug-Eluting Stents market trends in the 7MM (the United States, EU5 (Germany, France, Spain, Italy, and the United Kingdom), and Japan).&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Some of the Key Highlights from the Drug-Eluting Stents Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">The major companies active in the Drug-Eluting Stents market include <strong>Abbott, Braun Melsungen AG, Biosensors International Group, Ltd, BIOTRONIK SE &amp; Co. KG, Boston Scientific Corporation, Terumo Corporation, Medtronic, MicroPort Scientific Corporation, Lepu Medical, Cook, Medinol Ltd, Cardinal Health,<\/strong> among others.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">The FDA-approved Drug-Eluting Stents available in the market include <strong>EluNIR, SYNERGY&trade; XD, XIENCE SIERRA, Coroflex&reg; ISAR NEO, BA9&trade;, Orsiro,<\/strong> and several others.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>SYNERGY<\/strong> <strong>XD<\/strong> by <strong>Boston Scientific Corporation<\/strong> is a bioabsorbable everolimus-eluting stent of the next generation.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>EluNIR<\/strong> by <strong>Medinol<\/strong> is the first drug-eluting stent made of elastomeric material. It&#8217;s made from a thin cobalt-chrome alloy. Ridaforolimus Eluting Coronary Stent System is a stent known for its unique flexibility, conformability, and scaffolding.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">The Drug-Eluting Stents market is segmented by <strong>Type, Scaffold, and End Users.<\/strong><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">Request for the Webex demo of the report @ <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/drug-eluting-stents-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Drug-Eluting Stents Market Outlook<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Drug-Eluting Stents: Overview<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">Stents are small, expandable tubes that are inserted following percutaneous coronary intervention (PCI) to keep arteries open and improve blood flow. Stents are divided into two types: bare-metal stents and drug-eluting stents. Drug-Eluting Stents are coated with medications that slowly elute to prevent scar tissue buildup in the artery lining.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Drug-Eluting Stents Market<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">The total Drug-Eluting Stents market size is segmented by type, which includes coronary and peripheral stents. The Drug-Eluting Stents market is expected to grow due to a shift in preference for drug-eluting stents over angioplasty. The Drug-Eluting Stents market is expected to grow due to a change in preference for drug-eluting stents over angioplasty. The growing burden of the elderly population, combined with a sedentary lifestyle, is expected to increase the prevalence of atherosclerosis, thereby fueling the Drug-Eluting Stents market. Furthermore, the demand for minimally invasive procedures is a driving factor.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">Find out which player or device is going to get the maximum share @ <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/drug-eluting-stents-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Drug-Eluting Stents Market Size<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Drug-Eluting Stents Key Companies<\/strong>&nbsp;<\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Abbott<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Braun Melsungen AG<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Biosensors International Group, Ltd<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">BIOTRONIK SE &amp; Co. KG<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Boston Scientific Corporation<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Terumo Corporation<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Medtronic<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">MicroPort Scientific Corporation<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Lepu Medical<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Cook<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Medinol Ltd<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Cardinal Health<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Drug-Eluting Stents Market Drivers<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Increase in prevalence of artery blockage due to sedentary lifestyle and growing geriatric population<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Technological advancement in the field of drug-eluting stenting<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Drug-Eluting Stents Market Barriers<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">The risk associated with the stents<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">The dearth of skilled healthcare professionals<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Drug-Eluting Stents Unmet Needs<\/strong>&nbsp;<\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Incomplete inhibition of restenosis (especially in complex lesions)<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Scope for the Report<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Coverage:<\/strong> 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan)<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Study Period:<\/strong> 2018-26<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Drug-Eluting Stents Key Companies:<\/strong> Abbott, Braun Melsungen AG, Biosensors International Group, Ltd, BIOTRONIK SE &amp; Co. KG, Boston Scientific Corporation, Terumo Corporation, Medtronic, MicroPort Scientific Corporation, Lepu Medical, Cook, Medinol Ltd, Cardinal Health, among others.&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Tools Used:<\/strong> PEST Analysis<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>KOL&rsquo;s Views<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Table of Contents<\/strong>&nbsp;<\/p>\n<div style=\"text-align: justify;\" dir=\"ltr\" align=\"left\">\n<table>\n<colgroup>\n<col width=\"70\" \/>\n<col width=\"554\" \/><\/colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\">1.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Key Insights<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">2.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Executive Summary of Drug-Eluting Stents&nbsp;<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">3.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Drug-Eluting Stents: Background and Overview<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">4.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Drug-Eluting Stents: Regulatory Framework<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">5.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Drug-Eluting Stents: Reimbursement Scenario<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">6.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Drug-Eluting Stents Company Profiles<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">7.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Drug-Eluting Stents: Competitive Analysis of Listed Products<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">8.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Drug-Eluting Stents: KOL Views<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">9.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Drug-Eluting Stents: Market Analysis in 7MM<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">10.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Country-Wise Market size of Drug-Eluting Stents in 7MM<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">11.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Drug-Eluting Stents Market Dynamics<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">12.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">PEST Analysis<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">13.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Conclusion and Future perspective<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">14.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Appendix<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">15.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">DelveInsight Capabilities<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">16.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Disclaimer<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">17.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">About DelveInsight<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\">Get in touch with our business executive for <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/consulting\/due-diligence-services?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Healthcare Due Diligence Services<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Related Reports<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/coronary-stents-market-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Coronary Stents Market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">Get a comprehensive analysis of Coronary Stents pipeline devices and key companies, including <strong>Medtronic, Abbott, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE &amp; Co. KG, B. Braun Melsungen AG,<\/strong> among others.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com\/_57048.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Sandeep Joshi<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=the-growing-geriatric-population-is-expected-to-drive-the-growth-of-drugeluting-stents-market\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=the-growing-geriatric-population-is-expected-to-drive-the-growth-of-drugeluting-stents-market\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Drug-Eluting Stents Market The Drug-Eluting Stents market is expected to grow due to a change in preference for drug-eluting stents over angioplasty. DelveInsight&rsquo;s Drug-Eluting Stents market report provides a thorough comprehension of Drug-Eluting Stents and historical and forecasted Drug-Eluting Stents &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/the-growing-geriatric-population-is-expected-to-drive-the-growth-of-drugeluting-stents-market_576484.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,411,403,404],"tags":[],"class_list":["post-576484","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Technology","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/576484","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=576484"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/576484\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=576484"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=576484"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=576484"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}